PETER Mullan knew I Swear would enjoy the sweet smell of success when staff in airport Duty Free shops started puffing up the Scots film. The actor is a veteran of scores of major movie and TV ...

Our round-up of biotech financings is led this week by Braveheart Bio, a San Francisco biotech that has launched with $185 million, a lead drug for hypertrophic cardiomyopathy (HCM), and Biogen CEO ...

The best VHS to DVD converters will help you chew through that pile VHS or camcorder tapes gathering dust, and perserve your precious recordings as digital files. Given that analog recordings can and ...

Bristol Myers Squibb currently has the only drug approved specifically for treating obstructive hypertrophic cardiomyopathy, a debilitating disorder that can progress to heart failure. But safety ...

With $185 million in series A funding and an army of experienced leaders in its ranks, Braveheart Bio is setting off to joust with big names in an emerging heart disease drug arena. Backed by ...

Braveheart is one of many startups to recently turn to China-originated companies to build a pipeline. Its licensing deal with Hengrui, worth potentially more than $1 billion, was one of at least 20 ...

Board to include Chris Viehbacher as Chair, with investor syndicate led by Andreessen Horowitz, Forbion, and OrbiMed with participation from Enavate Sciences (a platform of Patient Square Capital) and ...

The film "Braveheart," lauded for its cinematic achievements, takes considerable liberties with historical accuracy. Released in 1995, it garnered acclaim, earning 31 out of 61 award nominations, ...

Write terminal GIFs as code for integration testing and demoing your CLI tools. The above example was generated with VHS (view source). Tape files consist of a series of commands. The commands are ...

Braveheart Bio has waded into the fight for a heart disease market, paying (PDF) $65 million upfront for a rival to Bristol Myers Squibb’s Camzyos and Cytokinetics’ aficamten. Jiangsu Hengrui ...